4.7 Article

Respiratory Syncytial Virus Hospitalization During Pregnancy in 4 High-income Countries, 2010-2016

期刊

CLINICAL INFECTIOUS DISEASES
卷 67, 期 12, 页码 1915-1918

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciy439

关键词

pregnancy; respiratory syncytial virus; epidemiology; vaccines; respiratory infections

资金

  1. CDC [HHSD2002013M53890B, 200-2014-F-60406]
  2. PHO
  3. ICES - MOHLTC

向作者/读者索取更多资源

Few studies have addressed respiratory syncytial virus (RSV) infection during pregnancy. Among 846 pregnant women hospitalized with respiratory illness and tested for RSV, 21 (2%) were RSV positive, of whom 8 (38%) were diagnosed with pneumonia. Despite study limitations, these data can help inform decisions about RSV prevention strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Health Care Sciences & Services

Disparities in Prenatal Immunization Rates in Rural and Urban US Areas by Indicators of Access to Care

Ravneet Kaur, Timothy Callaghan, Annette K. Regan

Summary: This study evaluated disparities in urban-rural immunization rates among pregnant women by indicators of access to health care. The findings suggested that pregnant women residing in rural areas relied more on Medicaid for prenatal care, but had less access to Medicaid coverage, leading to disparities in vaccine uptake and increased rates of vaccine-preventable diseases.

JOURNAL OF RURAL HEALTH (2023)

Article Obstetrics & Gynecology

Timing and temporal trends of influenza and pertussis vaccinations during pregnancy in three Australian jurisdictions: The Links2HealthierBubs population-based linked cohort study, 2012-2017

Lisa Mchugh, Paul Van Buynder, Mohinder Sarna, Ross M. Andrews, Hannah C. Moore, Michael J. Binks, Gavin Pereira, Christopher C. Blyth, Karin Lust, Damien Foo, Annette K. Regan

Summary: This study aims to investigate the gaps and predictors of influenza and pertussis vaccinations during pregnancy in Australia. The study found inequity in vaccine uptake between First Nations and non-Indigenous pregnancies, as well as low overall vaccination rates. If the pertussis vaccine is driving the uptake of influenza vaccine, changes in antenatal healthcare practices are needed to protect against infection.

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2023)

Article Pediatrics

Association between maternal influenza vaccination and neurodevelopmental disorders in childhood: a longitudinal, population-based linked cohort study

Damien Foo, Mohinder Sarna, Gavin Pereira, Hannah C. Moore, Annette K. Regan

Summary: This retrospective cohort study examined the association between in utero exposure to seasonal inactivated influenza vaccine (IIV) and the risk of a diagnosis of a neurodevelopmental disorder in early childhood. The results showed that there was no increased risk of neurodevelopmental disorders following in utero exposure to seasonal IIV. However, there was some evidence suggesting that exposure during the first trimester may reduce the risk of seizure disorders, and exposure in preterm children may reduce the risk of sleep disorders.

ARCHIVES OF DISEASE IN CHILDHOOD (2023)

Article Infectious Diseases

The seasonality of respiratory syncytial virus in Western Australia prior to implementation of SARS-CoV-2 non-pharmaceutical interventions

Cara A. Minney-Smith, David A. Foley, Chisha T. Sikazwe, Avram Levy, David W. Smith

Summary: The seasonality of respiratory syncytial virus (RSV) in Western Australia (WA) is influenced by local climate. Before the SARS-CoV-2 pandemic, RSV seasons in the Metropolitan and Southern regions of WA were consistent in timing and intensity, while the Northern region did not experience a distinct seasonality.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Article Pediatrics

A surge in human metapneumovirus paediatric respiratory admissions in Western Australia following the reduction of SARS-CoV-2 non-pharmaceutical interventions

David A. Foley, Daniel K. Yeoh, Cara A. Minney-Smith, Christine Shin, Briony Hazelton, Tobias Hoeppner, Hannah C. Moore, Mark Nicol, Chisha Sikazwe, Meredith L. Borland, Avram Levy, Chris C. Blyth

Summary: The study examines the impact of a surge in hMPV cases on pediatric hospital admissions and the influence of changes in testing. Results show that hMPV-positive admissions in 2021 were significantly higher than the baseline period, particularly in children aged 1-4 years and those with other acute lower respiratory infection. The increase in testing contributed to the higher number of hMPV-positive cases, suggesting a genuine rise in hMPV infections.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2023)

Editorial Material Public, Environmental & Occupational Health

The 'ins' and 'outs' of interpregnancy interval effects: Who contributes, and does it matter?

Annette K. Regan, Gavin Pereira

PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2023)

Article Immunology

COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study

Amelia K. Wesselink, Sharonda M. Lovett, Janice Weinberg, Ruth J. Geller, Tanran R. Wang, Annette K. Regan, Mary D. Willis, Rebecca B. Perkins, Jennifer J. Yland, Martha R. Koenig, Kenneth J. Rothman, Elizabeth E. Hatch, Lauren A. Wise

Summary: We conducted a prospective cohort study to examine the association between COVID-19 vaccination and menstrual cycle characteristics. Our findings suggest that COVID-19 vaccination is associated with a temporary increase in menstrual cycle length by 1 day, but not with other menstrual cycle characteristics.

VACCINE (2023)

Article Economics

Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults

Annette K. Regan, Pallavi Aytha Swathi, Marcianna Nosek, Ning Yan Gu

Summary: This study used EQ-5D-5L to assess health-related quality of life (HRQoL) during pregnancy and postpartum. The results showed a gradual increase in the use of EQ-5D-5L and a decline in its utility values until the ninth month of pregnancy. The values increased during the first postpartum month and then stabilized. The study indicates a decline in HRQoL during pregnancy and a recovery postpartum.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2023)

Article Obstetrics & Gynecology

A prospective cohort study of preconception COVID-19 vaccination and miscarriage

Jennifer J. Yland, Amelia K. Wesselink, Annette K. Regan, Elizabeth E. Hatch, Kenneth J. Rothman, David A. Savitz, Tanran R. Wang, Krista F. Huybrechts, Sonia Hernandez-Diaz, Michael L. Eisenberg, Lauren A. Wise

Summary: COVID-19 vaccination in either partner at any time before conception is not associated with an increased rate of miscarriage.

HUMAN REPRODUCTION (2023)

Article Obstetrics & Gynecology

Risk of Miscarriage in Relation to Seasonal Influenza Vaccination Before or During Pregnancy

Annette K. Regan, Amelia K. Wesselink, Tanran R. Wang, David A. Savitz, Jennifer J. Yland, Kenneth J. Rothman, Elizabeth E. Hatch, Lauren A. Wise

Summary: This study evaluated the association between seasonal influenza vaccination and miscarriage. The results showed that there was no significant association between receiving influenza vaccination before or during pregnancy and the risk of miscarriage.

OBSTETRICS AND GYNECOLOGY (2023)

Article Immunology

Determining the true incidence of seasonal respiratory syncytial virus-confirmed hospitalizations in preterm and term infants in Western Australia

Mohinder Sarna, Amanuel Gebremedhin, Peter Richmond, Avram Levy, Kathryn Glass, Hannah C. Moore

Summary: Respiratory syncytial virus is a major cause of illness and death in infants worldwide. By analyzing pre-pandemic RSV testing data and hospital admission data, a statistical prediction model was used to estimate RSV-hospitalizations in infants under 1 year old. The highest incidence rate of RSV-hospitalization in infants under 6 months was found in those born in April/May.

VACCINE (2023)

Editorial Material Immunology

Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy

Annette K. Regan, Deshayne B. Fell, Lauren A. Wise, Gabriela Vazquez-Benitez, Siri E. Haberg, Comfort Ogar, Jennifer J. Yland, Amelia K. Wesselink, Ousseny Zerbo

VACCINE (2023)

Article Immunology

Factors Predicting Secondary Respiratory Morbidity Following Early-Life Respiratory Syncytial Virus Infections: Population-Based Cohort Study

Mohinder Sarna, Amanuel Gebremedhin, Peter C. Richmond, Kathryn Glass, Avram Levy, Hannah C. Moore

Summary: This study examined the association between sociodemographic and perinatal factors and childhood respiratory morbidity following early-life respiratory syncytial virus (RSV) infection. The results showed that in addition to preterm and young infants, children aged 12-<24 months could also be potential target groups for RSV prevention.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Infectious Diseases

End-of-season influenza vaccine effectiveness during the Southern Hemisphere 2022 influenza season-Chile, Paraguay, and Uruguay

Anna N. Chard, Francisco Nogareda, Annette K. Regan, Marta Fernanda Olivares Barraza, Rodrigo A. Fasce, Natalia Vergara, Marcela Avendano, Elena Penayo, Cynthia Vazquez, Marta Von Horoch, Fabiana Michel, Adriana Alfonso, Cristina Mogdasy, Hector Chiparelli, Natalia Goni, Miguel Alegretti, Sergio Loayza, Paula Couto, Angel Rodriguez, Daniel Salas, Ashley L. Fowlkes, Eduardo Azziz-Baumgartner

Summary: This study estimated the vaccine effectiveness (VE) against severe acute respiratory illness (SARI) hospitalization in Chile, Paraguay, and Uruguay during the 2022 influenza season. The results showed that the VE against any influenza-associated SARI hospitalization was 33.8%, and the VE against influenza A(H3N2)-associated SARI hospitalization was 30.4%. VE estimates were similar across target populations.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023

Ashley L. Fowlkes, Francisco Nogareda, Annette Regan, Sergio Loayza, Jose Mendez Mancio, Lindsey M. Duca, Paula Couto, Juliana Leite, Angel Rodriguez, Daniel Salas, REVELAC i Network

Summary: Evaluations of vaccine effectiveness in the Southern Hemisphere influenza season indicate that vaccines substantially reduce the risk of severe influenza illnesses. In preparation for the Northern Hemisphere influenza season, it is recommended to encourage eligible individuals, especially those at increased risk for severe outcomes, to receive influenza vaccination.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2023)

暂无数据